Department of Bioengineering and Therapeutic Sciences

Dean Kathy Giacomini shares how the School’s recent breakthroughs and accomplishments are bringing our new strategic plan to life.

Scientists have shown for the first time that kidney cells—housed in an implantable device called a bioreactor—can survive while implanted.

A delegation from South Korea visited to sign a Memorandum of Understand (MOU) initiating potential collaborations between UCSF and Korean schools of pharmacy.

This ninth year of awards focuses on research advancing health and furthering understanding related to cancer, diabetes, HIV testing, immune response, and more.

All faculty are invited to the following networking and development events.

Assistant Professor

ADMIN OFCR 3

Having worked in higher education at UC Berkeley, Stanford University, and UCSF, I enjoy supporting students, faculty, and programs where I value equity, teamwork, and community to assist people in changing the world through engineering, curiosity, and innovation. During my time not at work, you...

James Fraser, PhD, plans to build on department strengths in computational biology and promote open science.

The FDA announces the Centers of Excellence in Regulatory Science and Innovation (CERSI) renewals, granting up to $50M for UCSF’s joint effort with Stanford.

Award from her alma mater recognizes Giacomini as a leading scientist and pharmacogenomics expert.